Atala Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Hold
1,851
0.14% 110
2026
Q1
$259K Hold
1,851
0.17% 101
2025
Q4
$227K Sell
1,851
-84
-4% -$10.2K 0.14% 113
2025
Q3
$215K Hold
1,935
0.13% 121
2025
Q2
$215K Hold
1,935
0.15% 120
2025
Q1
$217K Sell
1,935
-100
-5% -$10.3K 0.16% 112
2024
Q4
$188K Buy
+2,035
New +$183K 0.13% 121

Other funds holding GILD

Atala Financial's GILD Position: Q2 2026 in Review

Atala Financial held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,851 shares worth $234K. The position accounts for 0.14% of the portfolio, ranked #110.

Atala Financial first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $259K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Atala Financial held 1,851 shares of Gilead Sciences worth $234K as of Q2 2026.
  • Atala Financial left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.14% of Atala Financial's portfolio in Q2 2026, its #110 holding.
  • Atala Financial first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Atala Financial's Gilead Sciences position peaked at $259K in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Atala Financial's 13F filing for Q2 2026, filed 23 Jul 2026.